Open Access. Powered by Scholars. Published by Universities.®

Medicine and Health Sciences Commons

Open Access. Powered by Scholars. Published by Universities.®

Surgery

Zucker School of Medicine at Hofstra/Northwell

2015

Allograft;; anemia;; immunosuppression;; intravenous immunoglobulin;; parvovirus B19;; renal transplant

Articles 1 - 1 of 1

Full-Text Articles in Medicine and Health Sciences

Effects Of Parvovirus B19 Infection In Renal Transplant Recipients: A Retrospective Review Of Three Cases, P. Krishnan, P. Ramadas, P. P. Rajendran, P. Madhavan, A. Alex, V. Jayaschandran, S. G. Humayun, N. Ali, M. Sachdeva, A. Flecha, A. Basu, M. Bhaskaran, E. P. Molmenti Jan 2015

Effects Of Parvovirus B19 Infection In Renal Transplant Recipients: A Retrospective Review Of Three Cases, P. Krishnan, P. Ramadas, P. P. Rajendran, P. Madhavan, A. Alex, V. Jayaschandran, S. G. Humayun, N. Ali, M. Sachdeva, A. Flecha, A. Basu, M. Bhaskaran, E. P. Molmenti

Journal Articles

Parvovirus B19 (PVB19) is a DNA virus which causes clinically relevant infection in renal transplant recipients (RTR) leading to significant morbidity. Manifestations include erythropoietin resistant anemia, proteinuria, and glomerulosclerosis in the allograft. Severe infection may require administration of intravenous immunoglobulin, reduction in immunosuppression and transfusions. The major challenge in managing and preventing the infection in RTR involves the act of balancing the decreased level of immunosuppression and the risk of rejection. The objective of this article is to understand the importance of PVB19 infection and its outcome in RTR. We reviewed the medical records of three RTR with confirmed PVB19 …